Healthcare isn't the hottest sector these days. While the S&P 500 has soared nearly 21% over the last 12 months, healthcare ...

Trinasolar announced that UL Solutions has granted Trina's Vertex N 2,000-V solar panel UL 61730 certification. UL 61730 is ...

M Investment Round Highlights D-Fend’s Global Leadership in Counter-Drone Technology Across Industries With drones becoming ...

Ongoing launch of CASGEVY ® continues to gain momentum; new cell patient collection initiations expected to significantly grow in 2025- -More than 50 authorized treatment centers (ATCs) activated ...

Here’s everything you need to know about the latest Google Gemini 2.0 update, including new AI models like Flash, Pro, and ...

Vertex Pharmaceuticals Incorporated VRTX reported adjusted earnings of $3.98 per share for the fourth quarter of 2024, ...

Q4 2024 Earnings Call Transcript February 10, 2025 Vertex Pharmaceuticals Incorporated misses on earnings expectations. Reported EPS is $3.98 EPS, expectations were $4.02. Operator: Good day, and ...

Morgan Stanley analyst Terence Flynn raised the firm’s price target on Vertex Pharmaceuticals (VRTX) to $459 from $450 and keeps an Equal ...

A study published in the Journal of Cosmology and Astroparticle Physics (JCAP) presents a methodology to test the assumption ...

By Rick Winterson  Vertex Pharmaceuticals is a worldwide biotechnology corporation. It was founded 35 years ago in Cambridge.  It has now established its global headquarters on Fan Pier in South ...

Plus, developers and subscribers can try Gemini 2.0 Pro Experimental. A lighter, cheaper model, Gemini 2.0 Flash-Lite, hit ...

The US Food and Drug Administration (FDA) has approved Journavx, a new pain reliever without the risks of addiction or overdose linked to drugs like Vicodin and OxyContin.